Beam Therapeutics (BEAM) EBITDA Margin Growth (1y) (2020 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | 3,609.00 |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | 1,536.00 |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | -957.00 |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | 8,807.00 |
| 10 | Beam Therapeutics | 3.40 Bn | 3.40 Bn | - | 115,310.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 115,310.00 |
| Dec 31, 2025 | 51,847.00 |
| Sep 30, 2025 | -49,698.00 |
| Jun 30, 2025 | -43,497.00 |
| Mar 31, 2025 | -10,500.00 |
| Dec 31, 2024 | -35,009.00 |
| Sep 30, 2024 | -9,843.00 |
| Jun 30, 2024 | -35,735.00 |
| Mar 31, 2024 | -96,056.00 |
| Dec 31, 2023 | 22,618.00 |
| Sep 30, 2023 | 13,769.00 |
| Jun 30, 2023 | 2,327.00 |
| Mar 31, 2023 | 46,080.00 |
| Dec 31, 2022 | -5,335.00 |
| Sep 30, 2022 | 299,014.00 |
| Jun 30, 2022 | 126.95 Mn |
| Mar 31, 2022 | 335.87 Mn |
| Dec 31, 2021 | 159.18 Mn |
| Sep 30, 2021 | 57.27 Mn |
| Jun 30, 2021 | -70.83 Mn |
| Mar 31, 2021 | -284.60 Mn |
| Dec 31, 2020 | -112.72 Mn |
| Sep 30, 2020 | -25.91 Mn |
| Jun 30, 2020 | -26.54 Mn |